High-dose-rate plesiotherapy with customized molds in non-melanoma skin cancer: efficacy and safety at 10 years-single institution experience
- PMID: 34698997
- PMCID: PMC8885494
- DOI: 10.1007/s12094-021-02718-2
High-dose-rate plesiotherapy with customized molds in non-melanoma skin cancer: efficacy and safety at 10 years-single institution experience
Abstract
Purpose: Our center adopted high-dose-rate brachytherapy with surface applicators (plesiotherapy) in 2008, creating custom molds to treat irregular areas. This study describes the efficacy and safety outcomes after extensive follow-up in the patients.
Methods/patients: We planned the treatment using two computed tomography (CT) scans: the first to delineate the lesion and the second after placing the thermoplastic mold. Fusing the two CT images enables planning of the target volume and pinpointing, where the catheters are in the mold.
Results: Seventy patients received plesiotherapy, either exclusively or following excision in patients with risk factors for recurrence. Those receiving plesiotherapy alone showed a complete response rate of 95.8%, and recurrences occurred in 5.7% at a mean follow-up of 96.2 months. Chronic toxicity appeared in 26.6% of patients, but severity was limited to grade 1 or 2.
Conclusions: High-dose-rate brachytherapy with customized molds yields a high rate of complete response, with long-term recurrence rates in line with similar studies and an acceptable toxicity rate.
Keywords: Brachytherapy; Custom molds; Plesiotherapy; Skin cancer.
© 2021. The Author(s).
Conflict of interest statement
The authors have no conflicts of interest to declare that are relevant to the content of this article.
Figures




Similar articles
-
Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.Brachytherapy. 2015 Nov-Dec;14(6):859-65. doi: 10.1016/j.brachy.2015.09.001. Epub 2015 Oct 17. Brachytherapy. 2015. PMID: 26489922
-
High dose rate brachytherapy with customized applicators for malignant facial skin lesions.Cancer Radiother. 2016 Jul;20(5):341-6. doi: 10.1016/j.canrad.2016.03.008. Epub 2016 Jun 16. Cancer Radiother. 2016. PMID: 27321412
-
Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):95-102. doi: 10.1016/s0360-3016(99)00547-7. Int J Radiat Oncol Biol Phys. 2000. PMID: 10758310
-
Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy.Clin Transl Oncol. 2018 Apr;20(4):431-442. doi: 10.1007/s12094-017-1733-z. Epub 2017 Aug 14. Clin Transl Oncol. 2018. PMID: 28808925
-
Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer.J Dermatolog Treat. 2018 Mar;29(2):170-175. doi: 10.1080/09546634.2017.1341617. Epub 2017 Jun 30. J Dermatolog Treat. 2018. PMID: 28604229 Review.
Cited by
-
Iodine-125 plesiotherapy for murine tumor treatment.Radiat Oncol. 2025 May 16;20(1):78. doi: 10.1186/s13014-025-02657-0. Radiat Oncol. 2025. PMID: 40380214 Free PMC article.
References
-
- Sunlight, Vitamin D and Skin Cancer. In Reichrath J (ed) Advances in experimental medicine and biology. Springer International Publishing 2020; 10.1007/978-3-030-46227-7.
-
- Rubió-Casadevall J, Hernandez-Pujol AM, Ferreira-Santos MC, Morey-Esteve G, Vilardell L, Osca-Gelis G, Vilar-Coromina N, Marcos-Gragera R. Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: a population-based study. Cancer Epidemiol. 2016;45:6–10. doi: 10.1016/j.canep.2016.09.001. - DOI - PubMed
-
- Fania L, Didona D, Di Pietro FR, Verkhovskaia S, Morese R, Paolino G, Donati M, Ricci F, Coco V, Ricci F, Candi E, Abeni D, Dellambra E. Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches. Biomedicines. 2021;9(2):171. doi: 10.3390/biomedicines9020171. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical